Zacks Research Upgrades Nano-X Imaging (NASDAQ:NNOX) to Hold

Nano-X Imaging (NASDAQ:NNOXGet Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

Several other research firms also recently weighed in on NNOX. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, April 10th. D. Boral Capital reaffirmed a “buy” rating and set a $5.00 price target on shares of Nano-X Imaging in a research report on Monday, April 20th. Finally, Cantor Fitzgerald upgraded Nano-X Imaging to a “strong-buy” rating in a research note on Wednesday, March 4th. Three investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $5.00.

Check Out Our Latest Analysis on Nano-X Imaging

Nano-X Imaging Stock Performance

Shares of NNOX opened at $1.51 on Monday. Nano-X Imaging has a 1 year low of $1.50 and a 1 year high of $5.69. The stock has a market capitalization of $105.08 million, a PE ratio of -0.95 and a beta of 1.21. The stock has a 50-day simple moving average of $1.88 and a 200-day simple moving average of $2.43.

Nano-X Imaging (NASDAQ:NNOXGet Free Report) last posted its earnings results on Monday, April 20th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.35). Nano-X Imaging had a negative net margin of 790.87% and a negative return on equity of 64.65%. The business had revenue of $3.72 million during the quarter, compared to analysts’ expectations of $3.99 million. During the same period last year, the company earned ($0.21) EPS. Analysts predict that Nano-X Imaging will post -0.65 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in NNOX. Interchange Capital Partners LLC acquired a new stake in Nano-X Imaging in the fourth quarter valued at about $28,000. Aristides Capital LLC acquired a new position in Nano-X Imaging during the 4th quarter worth approximately $30,000. CIBC Bancorp USA Inc. purchased a new position in shares of Nano-X Imaging during the 3rd quarter worth approximately $40,000. Independent Financial Group LLC purchased a new position in shares of Nano-X Imaging during the 1st quarter worth approximately $26,000. Finally, Kestra Advisory Services LLC purchased a new position in shares of Nano-X Imaging during the 1st quarter worth approximately $26,000. 21.49% of the stock is currently owned by institutional investors and hedge funds.

Nano-X Imaging News Roundup

Here are the key news stories impacting Nano-X Imaging this week:

  • Neutral Sentiment: A class action lawsuit has been filed against Nano-X Imaging and certain officers, alleging securities-law violations during the March 31, 2025 to April 17, 2026 period. Article Title
  • Neutral Sentiment: Several plaintiff firms, including Rosen, Howard G. Smith, Schall, the Gross Law Firm, Faruqi & Faruqi, and others, issued notices reminding investors of the case and the August 11 lead-plaintiff deadline. Article Title
  • Negative Sentiment: The repeated lawsuit headlines may increase investor concern about potential financial liabilities and governance issues, adding pressure to an already weak stock. Article Title

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.

Further Reading

Analyst Recommendations for Nano-X Imaging (NASDAQ:NNOX)

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.